Healthy white adipose tissue (WAT) participates in regulating systemic metabolism, whereas dysfunctional WAT plays a prominent role in the development of obesity-associated co-morbidities. Tissue-resident immune cells are important for maintaining WAT homeostasis, including conventional dendritic cells (cDCs) which are critical in the initiation and regulation of adaptive immune responses. Due to phenotypic overlap with other myeloid cells, the distinct contribution of WAT cDCs has been poorly understood. This review will discuss the contribution of cDCs in the maintenance of WAT homeostasis. In particular, the review will focus on the metabolic cross-talk between cDCs and adipocytes that regulates local immune responses during physiological conditions.
Introduction
White adipose tissue (WAT) is an important store of energy, providing metabolic support to the body. Physiologically, WAT acts as an insulating layer with a protective function; it has also recently been recognized as a highly active metabolic and endocrine organ. WAT harbours immune cells in both healthy and pathological conditions, which work in cooperation with adipocytes to regulate metabolic homeostasis. However, during obesity, immune cells play a key role in the development of low-grade tissue inflammation, resulting in WAT dysfunction and the development of insulin resistance.
The roles of various immune cells in lean and obese WAT have been well described; however, the contribution of conventional dendritic cells (cDCs) is only beginning to be uncovered. The cDCs are professional antigen-presenting cells, with an important link between innate and adaptive immunity. They are considered a central component of the immune system due to their extraordinary capacity to initiate and modulate immune responses but also for their role in the maintenance of immune tolerance. Despite these key functions, the role of cDCs in WAT has been mostly studied in the context of obesity and low-grade tissue inflammation; less is known about their immunological role in WAT under steady-state conditions. In this review, we will discuss the putative role of cDCs in WAT and how they participate in maintaining tissue homeostasis.
Dendritic cells
Dendritic cells (DCs) are often referred to as 'sentinels' for the body, which sense and respond to environmental changes. Their primary function is antigen presentation to stimulate T-cell activation and to assist in the generation of primary antibody responses and enhance natural killer cytotoxicity. Conversely, DCs are vital for immune tolerance where they contribute to central and peripheral tolerance, which is fundamental to the maintenance of tissue immune homeostasis.
Migrating from the bone marrow, DC precursors enter every non-lymphoid tissue, where they reside in an immature state. They are specialized to sample the extracellular milieu and recognize pathogen-associated molecule patterns through the expression of pattern recognition receptors. These foreign proteins are processed by DCs, which undergo complex phenotypical and functional maturation involving the up-regulation of costimulatory molecules such as CD86, CD80, CD40 and Abbreviations: AT, adipose tissue; C/EBP, CCAAT/enhancer-binding proteins; cDC, conventional dendritic cell; CLV, collecting lymphatic vessel; DC, dendritic cell; FALC, fat-associated lymphoid cluster; GM-CSF, granulocyte-macrophage colony-stimulating factor; HIF1a, hypoxia inducible factor 1a; IL, interleukin; IRE1a, inositol-requiring enzyme 1a; LD, lipid droplet; MHC, major histocompatibility complex; moDC, monocyte-derived dendritic cell; PPARc, peroxisome proliferator-activated receptor-c; TG, triglyceride; Th17, T helper type 17; VAT, visceral adipose tissue; WAT, white adipose tissue; Xbp1, X-box binding protein 1 the secretion of cytokines and chemokines required for T-cell activation. Simultaneously, the chemotactic receptor CCR7 is up-regulated, enabling DC migration through the lymphatic system to the draining lymph node. Antigen presentation to naive T cells occurs in the lymph nodes by the major histocompatibility complex (MHC) molecules present on the DC surface. Different environmental signals to which DCs are exposed, influence the type of the immune responses initiated, including T helper cell polarization and tolerance induction.
Dendritic cells are subdivided into two main lineages; myeloid or conventional DCs (cDCs) and plasmacytoid DCs, which originate from DC progenitors in the bone marrow in the presence of Flt3 ligand. Plasmacytoid DCs play a major role in anti-viral immune responses characterized by the rapid production of type I interferon. 1 Conventional DCs are identified by high expression of MHCII and CD11c, and hence have a strong capability to capture and present antigens. They are considered a heterogeneous family of cells and are further categorized into two main subsets by their cell surface molecule expression, CD8 + CD103 + , termed cDC1, and CD11b + , termed cDC2. These subsets have different transcriptome profiles and lineage markers. 2 The expression of transcription factors interferon regulatory factor 8 and interferon regulatory factor 4, distinguishes between cDC1 and cDC2, respectively, and are required for their development and function. The cDC1 can efficiently recognize viral and intracellular antigens and have an intrinsic capacity to cross-present antigens to CD8 + T cells, while cDC2 preferentially promote CD4 + T cell responses and favour polarization towards T helper type 17 (Th17) and Th2 cell responses. During inflammation, a distinct population of monocyte-derived DCs (moDCs) have also been identified in tissues that originate from infiltrating monocytes. These cells can also be differentiated from monocytes in vitro using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4).
Due to phenotypic overlap with other myeloid cells, the distinct contribution of cDCs in WAT inflammation and tissue homeostasis has been poorly understood. A number of studies, which have been reviewed previously, have demonstrated that CD11c + MHCII + are present in WAT although it is unclear if these cells were activated macrophages, moDCs or cDCs. Although inconclusive, they suggest that DCs play an important role in the maintenance of obesity-induced tissue inflammation. 3 During obesity, the DC population expands and promotes a Th17-driven inflammatory response. [4] [5] [6] Ablating CD11c + cells, including macrophages and DCs, attenuates visceral adipose tissue (VAT) inflammation and recovery of glucose homeostasis in obese mice. 7 Collectively, these studies suggest that DCs adopt a pro-inflammatory state in obesity, whereas their function in WAT in steady-state conditions remains unclear. This review will explore the role of DCs and in particular cDCs, during WAT homeostasis and the potential regulatory mechanisms (Fig. 1) . Plasmacytoid DCs have low antigen-presenting capacity and, therefore, will not be discussed in this review. For clarity, in studies where the distinction between moDC and cDCs is unclear or contamination with monocytes/ macrophages is likely, cells will be referred to as DCs.
Adipose tissue
White adipose tissue is one of the body's connective tissues, comprised mainly of adipocytes but also containing pre-adipocytes, and mesenchymal stem and immune cells. It is widely distributed over the body in specific adipose depots; subcutaneous adipose tissue is located beneath the skin, VAT surrounds the internal organs and WAT is further found in the bone marrow and within muscles. 8, 9 By modulating lipid balance, WAT provides a reserve of energy; excess energy is stored in the form of triglyceride (TG) in adipocytes and mobilized through lipolysis to the circulation when required.
During changes in nutrient intake, WAT can respond rapidly and dynamically through a tightly regulated process of adipocyte expansion (hypertrophy) and adipogenesis (hyperplasia). Adipocyte differentiation is regulated by a cascade of transcriptional factors, including CCAAT/ enhancer-binding proteins (C/EBP) and peroxisome proliferator-activated receptor-c (PPARc) and signalling molecules such as Wnt proteins, which activate the canonical Wnt/b-catenin pathway. C/EBPa and PPARc cooperate to induce adipocyte differentiation through direct activation of genes in terminally differentiated adipocytes. Consequently, reduced adipose mass has been observed in PPARc and C/EBPa knockout mice. 10, 11, 12 Conversely, Wnt proteins inhibit the differentiation of pre-adipocytes, limiting hyperplasia. 13 Activation of the b-catenin pathway in transgenic mice over-expressing WNT10B in adipocytes prevents high-fat-diet-induced adipose tissue accumulation.
14 These regulatory processes are critical to maintaining WAT homeostasis.
Resident immune cells in VAT have been identified to fulfil crucial housekeeping functions in healthy tissue, to inhibit inflammation and maintain insulin sensitivity. 15 Adipose tissue macrophages are important in clearing apoptotic adipocytes, for the phagocytosis of tissue debris and controlling lipid cytotoxicity through the uptake of excess TGs and fatty acids. Anti-inflammatory cytokines such as IL-10, IL-4 and IL-13 are released by adipose tissue macrophages, natural killer T cells and eosinophils, to support an anti-inflammatory tissue environment. In addition, the high frequency of regulatory T cells producing IL-10 and transforming growth factor-b contributes to the suppressive immune phenotype of WAT. Hence, under physiological conditions, the tolerogenic state of WAT provides a systemic metabolic control of glucose homeostasis and insulin sensitivity.
Adipose tissue dendritic cells in steady-state

Antigen sampling
Collecting lymphatic vessels (CLVs) transport lymph from the tissue to the draining lymph nodes and are found to be encased in VAT. A recent study has demonstrated a dynamic feature of these vessels and proposes a mechanism by which VAT-cDC can 'sense' the tissue environment. 16 Kuan et al. observed that CLVs have an inherent permeability where the lymph components are released and distributed within the surrounding VAT. 16 The authors propose that cDCs closely associate with CLVs to uptake soluble antigens released from leaky CLVs and migrate to the lymph node for antigen presentation to T cells. Interestingly, vessel permeability can be compromised in obesity, diabetes and infections, facilitating antigen leakage into tissue and VAT-cDC uptake. In addition, it has been suggested that the interaction between cDCs and CVLs, a process that is controlled by the chemokine receptor CCR7, 17 contributes to the maintenance of vessel integrity. Ivanov et al. observed increased permeability and vessel fibrosis in CCR7 À/À mice; however, on recovery of CCR7 in cDCs the development of fibrosis was reversed. Antigen sampling is not limited to lymphatic vessels as VAT-cDCs are also observed in close proximity to blood vessels. 18 These studies suggest that VAT-cDCs are strategically located close to vessels to sample antigen and maintain vessel integrity, therefore contributing to the immune surveillance of neighbouring tissues.
In an elegant study, Fonseca et al. demonstrated how compromised lymphatic permeability disrupts VAT immune homeostasis, resulting from pathogenic assault on the gut. 19 It has been established that chronic inflammation is often triggered by infection; however, the authors have described a novel mechanism by which tissue immunity is persistently disturbed, even after the clearance of pathogen. In their model, an acute infection of the gut was sufficient to induce remodelling and inflammation of mesenteric VAT due to increased lymphatic vessel permeability and consequently altered migration of cDCs into the VAT. Deficient migration of cDCs into the draining lymph node and accumulation of these cells in the VAT compromised mucosal immunity, resulting in VAT dysfunction with the loss of tissue homeostasis.
Induction of T-cell responses
The distribution of lymphocytes in VAT is not homogeneous. They can localize in organized structures, referred to as fat-associated lymphoid clusters (FALCs) or milky spots (in the omentum), which are known to expand during inflammation. 20, 21 FALCs are considered inducible non-classical lymphoid tissues in direct contact with surrounding adipocytes. They are present in heterogeneous size and number within different adipose tissue depots. 22 Relatively, little is known about cDCs in FALCs. It has been shown in mucosal-associated lymphoid structures in the bronchus that the cDCs produce homeostatic chemokines and lymphoid cytokines, which are essential for their maintenance. 23 Furthermore, cDCs support the generation of adaptive immune responses through T-cell priming in these lymphoid structures in the bronchus. 24 It is therefore tempting to envisage that VAT-cDCs, through antigen uptake and presentation, may support the expansion and contraction of FALCs to modulate tissue immune responses and homeostasis.
A recent study by Han et al. proposes a novel physiological role for VAT as an important reservoir for memory T cells with long-term protective functions. 25 The authors show that mesenteric VAT harbours a large population of memory T cells, preferentially located in FALCs, with increased levels of homeostatic proliferation and Th1 biased effector function in steady-state conditions. These VAT-resident memory T cells exhibited a distinct metabolic profile compared with other tissue counterparts, indicated by increased lipid uptake and mitochondrial respiration. 25 In addition, these T cells were sufficient to confer protection against intestinal pathogen re-challenge. The authors claim that VAT is unlikely to be a site of T-cell priming, as antigen-specific T cells were not detected in the tissue during the initial phase of bacterial infection. It remains unclear how memory T cells can eventually migrate and locate in VAT and how this is regulated. However, it has been shown that milky spots in the omentum are exclusively responsible for responding to peritoneal antigens and promoting adaptive immune responses. 21 Much of this work has focused on CD11c + F4/80 + cells in the FALCs, which have been shown to process and present antigens to T cells residing in VAT. 26 The potential contribution of VAT-cDCs to the orchestration of immune responses in FALCs and the maintenance of local memory T cells is yet to be understood.
Cross-talk with adipocytes
Adipogenesis is an intricate and tightly regulated process that, if dysregulated, becomes an important contribution to metabolic disease in obesity. Pre-adipocytes are predominately located adjacent to adipose vasculature, where they differentiate to mature adipocytes. 27, 28 Interestingly, cDCs were also found in close proximity to adipose tissue vessels, suggesting a possible interaction with pre-adipocytes. Along these lines, a recent study has suggested a possible role of moDCs in regulating adipocyte expansion and differentiation through the cross-talk with pre-adipocytes. 29 GM-CSF is a growth factor for many myeloid cells including neutrophils, macrophages and moDCs. 30 GM-CSF knockout mice (Csf2 À/À ) exhibited larger adipocyte volume and differentiation under physiological conditions compared with control mice. 29 The increased adiposity was accompanied by a dramatic reduction of CD45 + F4/ 80 + CD11b + CD11c VAT-DCs. Moreover, pre-adipocyte differentiation was inhibited upon incubation with moDCconditioned medium, but not with bone marrow-derived macrophage supernatant, through a mechanism mediated by matrix metalloproteinase protein-12 and fibronectin-1 secretion. 29 As yet, the effect of cDCs in pre-adipocyte differentiation has not been investigated.
VAT-cDC cross-talk appears to modulate not only preadipocyte differentiation but also adipocyte function. Our work recently demonstrated that cDCs in VAT acquire a tolerogenic phenotype under physiological conditions by up-regulating pathways involved in adipocyte differentiation. 18 In VAT, the Wnt/b-catenin pathway keeps preadipocyte differentiation in check, while PPARc signalling allows adipocyte expansion to buffer excess of nutrients. Interestingly, cDC subsets differentially responded to these pathways in VAT. We demonstrated an up-regulation of the Wnt/b-catenin pathway in the VAT-cDC1 subset, which promoted an anti-inflammatory milieu in the tissue through enhanced IL-10 production. These results confirmed previous findings that activation of the Wnt/b-catenin pathway in cDC limits inflammatory responses. 31, 32 However, in the VAT-cDC2 subset, an upregulation of the PPARc pathway was observed, which is known to supress the onset of inflammatory responses by modulating transcriptional regulation of nuclear factorjB signalling. 33 Consequently, depletion of these pathways in cDCs using mice expressing the Cre recombinase in the highly cDC-specific Zbtb46 promoter accelerated the onset of obesity-induced tissue inflammation and insulin resistance. In chronic over-nutrition, the production of Wnt proteins decreases, in particular WNT10B, which promotes adipocyte hyperplasia. 34 Similarly, obesity induces a decline in PPARc expression and signalling due to post-transcriptional modifications. 35, 36 Hence, activation of these pathways in cDCs is curtailed, promoting a switch to a pro-inflammatory phenotype in VAT during obesity. These findings identify a novel mechanism by which cDCs maintain tissue immune homeostasis. Due to the specificity of the mouse model used in this study, it is unclear how these pathways regulate moDC function in VAT. However, it is known that PPARc is highly expressed in monocytes recruited to the inflammatory site and in the moDC population. 37, 38 In addition to the pathways mentioned above, other pathways associated with adipocyte function have also been linked with the regulation of cDC biology (Fig. 2) . Unfolded protein response is a complex signalling cascade activated by alteration of endoplasmic reticulum homeostasis. The inositol-requiring enzyme 1a (IRE1a)/X-box binding protein 1 (Xbp1) pathway is the most conserved branch of the unfolded protein response. 39 It has been suggested that during differentiation, adipocytes up-regulate the IRE1a/Xbp1 pathway to counteract the stress associated with protein and lipid biosynthesis. 40 In addition, during obesity, increased endoplasmic reticulum stress leads to up-regulation of the IRE1a/Xbp1 pathway. Overexpression of Xbp1 in adipocytes promotes adiponectin multimerization, improving systemic glucose homeostasis in vivo. 41 Interestingly, the Xbp1 pathway was found to be up-regulated in tumour-infiltrated DCs, resulting in the loss of immunostimulatory activity and inhibition of anti-tumour T-cell responses. 42 Therefore, it is feasible to hypothesize that activation of this pathway in WAT-DCs under steady-state conditions or during the onset of obesity, could contribute to the maintenance of the WAT anti-inflammatory milieu. In addition to endoplasmic reticulum stress, as adipocytes expand, hypoxic conditions develop due to the increased need for vascularization. Stabilization and accumulation of the transcription factor hypoxia inducible factor-1a (HIF1a) are observed in hypertrophic adipocytes, inducing a cellular metabolic switch promoting glycolysis and suppressing fatty acid oxidation. 43 HIF1a plays an essential role in mediating adaptive changes in cell metabolism during hypoxia to balance oxygen supply and demand. Interestingly, VAT expansion and dysfunction were attenuated in mice with adipocyte-specific Hif1a inactivation 43 and through pharmacological HIF1a inhibition in vivo, 44 in diet-induced obesity mouse models. These results suggest that hypoxia-induced gene transcription is detrimental for adipocyte health. Whereas in DCs HIF1a has been reported to play a crucial role in the activation of inflammation. 45, 46 Hypoxic conditions in combination with lipopolysaccharide stimulus modulate the maturation, activation and antigen-presenting capacity of moDCs and are dependent on HIF1a. 45 Similarly, to adipocytes, HIF1a accumulation demonstrated a metabolic reprogramming in moDCs, enhancing glycolytic activity, which Jantsch et al. propose is responsible for moDC activation. 45 However, in a recent study, up-regulation of HIF1a in DCs was critical to exacerbate inflammation in a Leishmania infection model, although in this study the authors suggest that HIF1a impaired DC function, decreasing IL-12 production and enhancing CD8 + T-cell expansion. 46 Hence, it is possible that cross-talk of the HIF1a pathway between adipocytes and VAT-cDCs during obesity may exacerbate tissue expansion and inflammation. Collectively, these findings imply that WAT immune homeostasis could be modulated by other adipocyte-related pathways in DCs, however further investigation is required to understand the exact mechanisms.
Lipolysis of adipocytes
Triglycerides in adipose tissue are the major energy reserve of the human body. During energy deprivation, adipocytes undergo a switch toward lipolysis resulting in the breakdown of TG into free fatty acids and glycerol. Lipolysis can be initiated not only during starvation, but also as a result of infections. This is particularly true for VAT surrounding lymph nodes, termed perinodal adipose tissue (PAT). Adipocytes in PAT exhibit distinct site-specific properties 47 that enable local interactions with the lymph node, for example changes in the adipocyte receptor profile. These local interactions modulate the lipolysis of adipocytes, which is exacerbated by immune stimuli such as tumour necrosis factor-a, IL-4 and IL-6 resulting in higher levels of lipolysis in PAT. 48 These findings suggest that PAT adipocytes directly interact with lymph nodes, responding to and supporting immunological processes. 49 Interestingly, DCs were located preferentially in PAT compared with other WAT depots. 50 It has been proposed that PAT-DCs elicit increased perinodal adipocyte lipolysis ex vivo. 51 Furthermore, Sadler et al. observed that PAT adipocytes elicit higher rates of lipolysis during low-grade inflammation. 51 Therefore, local interactions between VAT-cDCs and PAT may play an important role in maintaining lipid balance and immune responses in VAT.
Dendritic cells can uptake the fatty acids released from adipocytes, either for use as fuel or incorporated into their membrane. Alternatively, fatty acids are stored as TGs in lipid droplets (LDs) within the cell, which are increasingly recognized to play important roles in immune regulation. These LDs have been shown to facilitate metabolic processes and support immune responses including antigen cross-presentation, activation of interferon-induced proteins and pathogen clearance. 52 LDs are associated with increased DC immunogenicity, in which high levels of LD promote DC activation and enhanced effector T-cell stimulation. In a study sorting high-and low-lipid-containing DCs from the liver, Ibrahim et al. observed that lipid accumulation modulated DC function; lipid-rich DCs possessed immunogenic properties dependent on increased tumour necrosis factor-a secretion, whereas low-lipid DCs induced regulatory T cells and immune tolerance. 53 However, the effect of LD accumulation in cDCs is determined by the environmental context. In tumours, where there is an increased cellular demand for energy, innate immune cells contain a greater number of LDs compared with in healthy tissue. 54 Interestingly, in contrast to physiological conditions, Herber et al. showed that tumour infiltrated DCs exhibit high levels of LDs, which induce a dysfunctional phenotype with poor antigen-stimulatory capacity. 54 Furthermore, oxidized lipids generated in a tumour environment were shown to directly abrogate DC cross-presentation of antigens, whereas in physiological conditions only low levels of oxidized lipids accumulate in DCs. 55 Hence, the lipid content of LDs further determines DC function. Due to the lipid-rich environment of WAT, it is expected that cDCs will have increased lipid uptake and higher levels of TG storage in LDs, although the functional consequences of this remain unclear.
Effect of infection
During chronic inflammation when lymphatic permeability is compromised, WAT can act as a reservoir for viruses, bacteria and parasites. 56, 57 As discussed previously these pathogens may be cleared by immune responses located in the FALC; however, the milieu of WAT can be exploited by persistent infections. It is known that pathogens modulate WAT function, for example the bacteria Mycobacterium tuberculosis is known to infect adipocytes where it induces the expression of stress-related genes. 58 Parasites Trypanosoma cruzi and Trypanosoma brucei have been identified in WAT of mouse and man, where they invade the adipocyte cytoplasm and the interstitial adipose tissue space, respectively. 57 Trypanosoma cruzi, which causes Chagas disease, is known to inhibit lipid accumulation in adipocytes, decreasing adipocyte size, but increasing pro-inflammatory cytokine production. Subsequently WAT infected by T. cruzi demonstrates increased F4/80 + macrophage recruitment. 59 In addition, the subcutaneous adipose tissue environment is proposed to favour T. brucei growth, where the parasite tightly interacts with adipocytes, although the effect on host cells remains unclear. 57 Furthermore, viruses have been well documented to infect WAT, specifically human immunodeficiency virus (HIV) which evades hydrophilic antiretroviral treatment by exploiting the lipid-rich environment of WAT. 56 Damouche et al. showed that HIV infects WAT-resident CD4 + T cells promoting chronic tissue inflammation and viral persistence. Subsequently, modulation of adipocytes by persistent infections has the potential to indirectly alter WAT-cDC function.
Conclusion
The role of cDCs in WAT under physiological conditions remains largely unexplored. This review has outlined the potential mechanisms by which cDCs maintain WAT immune homeostasis, including antigen sampling, interaction with FALCs and modulation of immune responses. In addition, cDCs have the potential to modulate adipogenesis and lipogenesis of adipocytes through direct or indirect mechanisms, although this is yet to be clearly established. Further investigation is required to fully understand the role and mechanisms of WAT-cDC contribution to tissue homeostasis in steady-state. This will only be possible with the use of more specific mouse models and greater in-depth pathway analysis.
